Acid reflux cough treatment
Pro Research Analysisby 
Searched over 200M research papers
Acid Reflux Cough Treatment: First-Line Therapies and Effectiveness
Acid reflux-related cough, also known as gastroesophageal reflux-related cough (GERC), is commonly managed with acid-suppressive therapy as the first-line treatment. Proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) are the main medications used. Studies show that both PPIs (such as esomeprazole) and P-CABs (such as vonoprazan) significantly reduce cough severity and improve quality of life in patients with GERC, with P-CABs possibly offering greater improvement in classic reflux symptoms and overall quality of life after two months of treatment 1678+1 MORE.
Prokinetic agents are often used alongside acid-suppressive drugs to enhance treatment effects 12. In addition, lifestyle modifications, such as dietary changes and weight management, are recommended as supportive measures 6710.
Patient Selection and Diagnostic Considerations for Acid-Suppressive Therapy
The effectiveness of acid-suppressive therapy is higher in patients with objective evidence of abnormal esophageal acid exposure, as confirmed by reflux monitoring. Patients with chronic cough and proven gastroesophageal reflux disease (GERD) are more likely to benefit from these treatments, while those without clear reflux evidence show little to no improvement 3478. Therefore, careful patient selection using diagnostic tools like esophageal pH monitoring is important to identify those most likely to respond to therapy 3710.
Alternative and Adjunctive Treatments for Refractory Cases
For patients whose cough does not respond to standard acid-suppressive therapy, additional options are available. Baclofen, a neuromodulator, has shown moderate effectiveness in reducing cough symptoms in refractory GERC, though it may cause side effects such as drowsiness and fatigue 578. Neuromodulators in general and anti-reflux surgery are considered for persistent cases that do not improve with medication 67810.
Novel and Complementary Approaches
Recent research has explored the use of herbal medicine combinations, such as Ojeok-san plus Saengmaek-san, which have shown potential in reducing cough severity and improving gastrointestinal symptoms in GERC patients, with a good safety profile in pilot studies . However, larger studies are needed to confirm these findings.
Mechanisms and Inflammatory Markers
Successful anti-reflux treatment not only reduces cough symptoms but also appears to decrease neurogenic and neutrophilic inflammation, as indicated by reductions in substance P levels and sputum neutrophil counts in responders . This suggests that effective therapy may address both the physical reflux and the associated inflammatory processes.
Conclusion
Acid-suppressive therapy, particularly with PPIs and P-CABs, remains the cornerstone of treatment for acid reflux-related cough, especially in patients with confirmed GERD. Prokinetic agents and lifestyle modifications can further enhance outcomes. For refractory cases, neuromodulators and surgical options may be considered. Accurate diagnosis and patient selection are crucial for maximizing treatment success, and emerging therapies such as herbal medicines may offer additional options in the future.
Sources and full results
Most relevant research papers on this topic
Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.
Acid-suppressive therapy shows a therapeutic benefit for chronic cough patients, but rigorous patient selection is necessary to identify responsive populations.
P183 Chronic cough – efficacy of acid suppression therapy in asymptomatic gastroesophageal reflux
Acid suppression therapy is effective in symptomatic patients with gastroesophageal reflux disease, but its effectiveness in asymptomatic patients remains unclear.
Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.
Baclofen is a useful but suboptimal treatment option for refractory gastroesophageal reflux-induced chronic cough, improving symptoms in 56.3% of patients and reducing acid reflux episodes.
[Advances in internal treatment of gastroesophageal reflux-related cough].
Gastroesophageal reflux-related cough (GERC) treatment effectiveness is poor due to the lack of gold standard diagnostic criteria and various treatments, including acid-suppressive therapy, lifestyle modification, and endoscopic anti-reflux surgery.
DOI
[Diagnosis and treatment of gastroesophageal reflux-related cough: consensus and controversies].
Anti-acid drugs are the first-line choice for diagnosing gastroesophageal reflux-related cough, with neuromodulators and anti-reflux surgery potentially promising curative therapies.
DOI